Photosensitive Epilepsy Completed Phase 2 Trials for Selurampanel (DB12367)

IndicationStatusPhase
DBCOND0039388 (Photosensitive Epilepsy)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00784212Effect of BGG492 on EEG in Patients With Photosensitive EpilepsyTreatment